Pricing Log in Create free account

Equillium, Inc. (EQ) vs vTv Therapeutics Inc. (VTVT)

Equillium, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Equillium, Inc. and vTv Therapeutics Inc. are of similar size ($86.0M and $84.3M). vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against 13.9%. Across the 12 metrics below, Equillium, Inc. leads on 6 and vTv Therapeutics Inc. on 6.

Valuation

Metric EQ VTVT Biotechnology median
P/E n/m n/m 10.60
P/S 4.11 6.97 9.40
P/B 3.01 3.36 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.90 4.72 9.02
Earnings yield (13.25%) (3.62%) (32.88%)
Free cash flow yield (11.89%) (6.39%) (23.13%)

Profitability

Metric EQ VTVT Biotechnology median
Gross margin 100.00% 99.92% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (11.74%) (51.96%)
Return on assets (50.68%) (8.34%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ VTVT Biotechnology median
Revenue growth (TTM) 13.89% 654.58% 6.76%
EPS growth (last fiscal year) (69.57%) 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 12.48 4.97
Net debt to EBITDA 1.29 2.71 1.01

Dividend

Metric EQ VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EQ VTVT Biotechnology median
Market cap 84.33m 85.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack